Bright Scholar Education Holdngs (NYSE: LRN) and K12 (NYSE:LRN) are both small-cap consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, profitability, analyst recommendations and dividends.
Analyst Ratings
Get Bright Scholar Education Holdngs alerts:This is a summary of recent ratings and target prices for Bright Scholar Education Holdngs and K12, as reported by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bright Scholar Education Holdngs 0 0 3 0 3.00 K12 0 0 2 0 3.00Bright Scholar Education Holdngs presently has a consensus price target of $17.00, indicating a potential upside of 43.46%. K12 has a consensus price target of $20.50, indicating a potential upside of 19.39%. Given Bright Scholar Education Holdngs’ higher possible upside, analysts plainly believe Bright Scholar Education Holdngs is more favorable than K12.
Hot Dividend Stocks To Own For 2019: America First Tax Exempt Investors L.P.(ATAX)
Advisors' Opinion:- [By Motley Fool Transcribers]
America First Multifamily Investors LP (NASDAQ:ATAX)Q2 2018 Earnings Conference CallAug. 13, 2018, 4:30 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Shane Hupp]
Shares of America First Tax Exempt Investors, L.P. (NASDAQ:ATAX) hit a new 52-week high and low during mid-day trading on Monday . The company traded as low as $6.47 and last traded at $6.43, with a volume of 54800 shares changing hands. The stock had previously closed at $6.43.
- [By Stephan Byrd]
BidaskClub upgraded shares of America First Multifamily Investors (NASDAQ:ATAX) from a strong sell rating to a sell rating in a research report sent to investors on Thursday morning.
- [By Shane Hupp]
Get a free copy of the Zacks research report on America First Multifamily Investors (ATAX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot Dividend Stocks To Own For 2019: United Bancshares Inc.(UBOH)
Advisors' Opinion:- [By Logan Wallace]
United Bancshares Inc. OH (NASDAQ:UBOH) and Bank of America (NYSE:BAC) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability and analyst recommendations.
Hot Dividend Stocks To Own For 2019: ONEOK Inc.(OKE)
Advisors' Opinion:- [By Shane Hupp]
Here are some of the news articles that may have impacted Accern Sentiment’s rankings:
Get ONEOK alerts: Analysts Anticipate ONEOK, Inc. (OKE) Will Announce Earnings of $0.66 Per Share (americanbankingnews.com) ONEOK (OKE) PT Set at $72.00 by Barclays (americanbankingnews.com) MARKETS: Why Bloomberg sees King Dollar reclaiming the throne (finance.yahoo.com) Keeping Tabs on the Levels for ONEOK, Inc. (NYSE:OKE): Change of -0.04 Since the Bell (stocknewscaller.com) Alluring Stocks: Lloyds Banking Group plc, (NYSE: LYG), ONEOK, Inc., (NYSE: OKE) (globalexportlines.com)NYSE OKE traded up $0.22 on Tuesday, hitting $69.24. 1,729,000 shares of the stock were exchanged, compared to its average volume of 2,754,345. ONEOK has a 52-week low of $47.14 and a 52-week high of $69.84. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.49 and a current ratio of 0.63. The stock has a market cap of $28.14 billion, a price-to-earnings ratio of 39.34, a PEG ratio of 2.75 and a beta of 1.27.
- [By Matthew DiLallo]
Last year was an excellent one for ONEOK (NYSE:OKE). The pipeline giant was one of the best-performing energy stocks in the S&P 500, albeit in a down year for the market, thanks to a big uptick in earnings and cash flow through the third quarter. We'll find out later this week if that trend continued during the fourth quarter, which is one of a few things investors should keep an eye on when the pipeline giant reports earnings.
- [By Jon C. Ogg]
ONEOK Inc. (NYSE: OKE) was reiterated as Buy with a $67 price objective ahead of the earnings report due on the same day. The firm sees management providing 2019 guidance, updates on growth projects and color on the impact of commodity prices. Its shares were down 0.5% at $67.46 in midday trading on Monday.
- [By Lee Jackson]
The volatile price of natural gas over the past year has weighed some on this top energy stock. ONEOK Inc. (NYSE: OKE) primarily engages in natural gas transportation, storage and natural gas and natural gas liquids (NGLs) gathering, processing and fractionation in the Bakken, Mid-Continent and Permian. The company recently closed the roll-up of its underlying master limited partnership, ONEOK Partners.
- [By Joseph Griffin]
These are some of the news articles that may have effected Accern’s scoring:
UBS Upgrades ONEOK (OKE) to “Buy” (americanbankingnews.com) Early Moves to Watch – ONEOK Inc (NYSE: OKE) (stocksmarketcap.com) Oneok board increases dividend (journalrecord.com) Deutsche Bank Initiates Coverage on ONEOK (OKE) (americanbankingnews.com) Trading Psychology – Agilent Technologies, Inc. (A), ONEOK, Inc. (OKE) (nmsunews.com)OKE has been the subject of a number of recent research reports. Zacks Investment Research upgraded ONEOK from a “sell” rating to a “hold” rating in a research report on Friday, December 22nd. Royal Bank of Canada upgraded ONEOK from a “sector perform” rating to an “outperform” rating in a research report on Tuesday, January 16th. TheStreet downgraded ONEOK from a “b” rating to a “c+” rating in a research report on Monday, February 26th. Bank of America initiated coverage on ONEOK in a research report on Tuesday, January 9th. They set a “neutral” rating for the company. Finally, Wells Fargo upgraded ONEOK from a “market perform” rating to an “outperform” rating in a research report on Thursday, January 11th. Ten research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $61.13.
Hot Dividend Stocks To Own For 2019: S&P Smallcap 600(PH)
Advisors' Opinion:- [By Ethan Ryder]
Parker-Hannifin (NYSE:PH) had its price target boosted by Wells Fargo & Co from $185.00 to $193.00 in a research note released on Thursday, The Fly reports. Wells Fargo & Co currently has a market perform rating on the industrial products company’s stock.
- [By Shane Hupp]
Investors sold shares of Parker-Hannifin Corp (NYSE:PH) on strength during trading hours on Friday. $23.02 million flowed into the stock on the tick-up and $82.05 million flowed out of the stock on the tick-down, for a money net flow of $59.03 million out of the stock. Of all stocks tracked, Parker-Hannifin had the 25th highest net out-flow for the day. Parker-Hannifin traded up $2.45 for the day and closed at $171.53
- [By Logan Wallace]
Here are some of the news headlines that may have impacted Accern’s analysis:
Get Parker-Hannifin alerts: Zacks: Brokerages Anticipate Parker-Hannifin Corp (PH) Will Announce Quarterly Sales of $3.53 Billion (americanbankingnews.com) Brokerages Expect Parker-Hannifin Corp (PH) Will Announce Earnings of $2.49 Per Share (americanbankingnews.com) Parker-Hannifin Corp (PH) Receives Consensus Rating of “Hold” from Analysts (americanbankingnews.com) Parker-Hannifin (PH) Stock Rating Upgraded by Evercore ISI (americanbankingnews.com) ASM International Announces Parker Hannifin as First Client Member of ASM's Materials Solutions Network (prweb.com)Several research firms recently issued reports on PH. ValuEngine raised Parker-Hannifin from a “sell” rating to a “hold” rating in a research note on Tuesday, August 7th. Zacks Investment Research lowered Parker-Hannifin from a “hold” rating to a “sell” rating in a research note on Wednesday, June 27th. Wells Fargo & Co reissued a “market perform” rating on shares of Parker-Hannifin in a research note on Thursday, June 28th. MED lowered Parker-Hannifin from a “buy” rating to a “hold” rating and set a $169.00 target price on the stock. in a research note on Thursday, July 12th. Finally, Evercore ISI raised Parker-Hannifin from an “in-line” rating to an “outperform” rating in a research note on Monday, August 6th. Eleven analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Parker-Hannifin presently has an average rating of “Hold” and an average price target of $189.50.
- [By Shane Hupp]
Barings LLC decreased its holdings in Parker Hannifin (NYSE:PH) by 36.4% in the first quarter, HoldingsChannel reports. The firm owned 26,064 shares of the industrial products company’s stock after selling 14,937 shares during the period. Barings LLC’s holdings in Parker Hannifin were worth $4,458,000 as of its most recent SEC filing.
Hot Dividend Stocks To Own For 2019: Laboratory Corporation of America Holdings(LH)
Advisors' Opinion:- [By Shane Hupp]
These are some of the headlines that may have impacted Accern’s analysis:
Get LabCorp alerts: $2.92 Earnings Per Share Expected for LabCorp (LH) This Quarter (americanbankingnews.com) Global Contract Research Organization Market 2018 Pioneers by 2023: Parexel, LabCorp (Covance), PRA, PPD … (theexpertconsulting.com) OmniSeq and LabCorp Launch OmniSeq Advance? Assay (nasdaq.com) LabCorp’s latest collaboration aims to accelerate personalized, genomic medicine (bizjournals.com) Can Laboratory Corporation of America Holdings (NYSE:LH) Continue To Outperform Its Industry? (finance.yahoo.com)LH has been the topic of several analyst reports. Barclays lifted their target price on shares of LabCorp from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, February 26th. They noted that the move was a valuation call. Zacks Investment Research raised shares of LabCorp from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Friday, February 9th. Jefferies Group reaffirmed a “hold” rating and issued a $176.00 target price on shares of LabCorp in a research note on Tuesday, March 6th. ValuEngine raised shares of LabCorp from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Finally, Morgan Stanley lifted their target price on shares of LabCorp from $182.00 to $192.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 28th. Five research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. LabCorp has an average rating of “Buy” and an average target price of $191.06.
- [By Garrett Baldwin]
If you're looking to get your share of a booming, global growth story, look no further than Laboratory Corp. of America Holdings (NYSE: LH).
The Burlington, North Carolina-based company operates the largest network of clinical laboratories in the world. Its U.S. network has 36 labs and processes 2.5 million lab tests every week.
- [By Stephan Byrd]
Laboratory Corp. of America Holdings (NYSE:LH) – Stock analysts at SunTrust Banks cut their Q1 2019 earnings per share (EPS) estimates for shares of Laboratory Corp. of America in a research report issued to clients and investors on Tuesday, September 11th. SunTrust Banks analyst D. Macdonald now forecasts that the medical research company will earn $2.83 per share for the quarter, down from their previous forecast of $2.94. SunTrust Banks has a “Buy” rating and a $220.00 price target on the stock. SunTrust Banks also issued estimates for Laboratory Corp. of America’s Q2 2019 earnings at $3.05 EPS, Q4 2019 earnings at $3.10 EPS, FY2019 earnings at $12.06 EPS and FY2020 earnings at $13.04 EPS.
- [By Ethan Ryder]
Laboratory Corp. of America Holdings (NYSE:LH) has been assigned a consensus rating of “Buy” from the eighteen ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $196.64.
- [By Joseph Griffin]
Envestnet Asset Management Inc. reduced its position in shares of LabCorp (NYSE:LH) by 45.1% during the first quarter, HoldingsChannel.com reports. The fund owned 19,179 shares of the medical research company’s stock after selling 15,727 shares during the quarter. Envestnet Asset Management Inc.’s holdings in LabCorp were worth $3,116,000 at the end of the most recent reporting period.
No comments:
Post a Comment